Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B

doi:10.3748/wjg.v13.i30.4096

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2143)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

253

HTML

1682

Tables (1-2)

208

Sum=2143

Aug 14, 2007 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 14, 2007; 13(30): 4096-4099
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4096

Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B

Paolo Del Poggio, Maurizio Zaccanelli, Maria Oggionni, Silvia Colombo, Carlo Jamoletti, Vesna Puhalo

Paolo Del Poggio, Silvia Colombo, Carlo Jamoletti, Vesna Puhalo, Hepatology Unit, Treviglio Hospital (Bg), Italy

Maurizio Zaccanelli, Maria Oggionni, Blood Bank (Molecular Biology Section), Treviglio Hospital (Bg), Italy

Author contributions: All authors contributed equally to the work.

Correspondence to: Paolo Del Poggio, Hepatology Unit, Treviglio Hospital, Piazza Ospedale 1, 24047 Treviglio (Bg), Italy. pdpoggio@ospedale.treviglio.bg.it

Telephone: +39-36-3424494 Fax: +39-36-3424561

Received: April 23, 2007
Revised: May 3, 2007
Accepted: May 28, 2007
Published online: August 14, 2007

Core Tip